SLC34A2 and facioscapulohumeral muscular dystrophy: Specifically, Dr. Malecova reported reductions in 4 DUX4 target genes (QPCR) and SLC34A2 protein (immunofluorescence) in 11 different human FSHD myotube lines treated with 10 nM siRNA.